About this trial
Postpartum hemorrhage and anemia are considered a major health concern due to their impact on maternal morbidity and mortality, quality of life, and maternal cognitive and emotional functioning after delivery, which are particularly important during the critical period of mother-child bonding. Hemoglobin levels in the first 24 hours after delivery do not reflect the lowest point (nadir). The postpartum nadir occurs 48-72 hours after delivery due to the initial redistribution of plasma volume. The aim of this study was to examine whether postpartum ultrasound examination precedes laboratory test results in the diagnosis of anemia due to blood loss after cesarean section.
Eligibility criteria
Qualifiers
Women who delivered by a cesarean section.
Age over 18.
Fluent in Hebrew or Arabic.
Signed informed consent form.
Disqualifiers
Lack of consent or inability to provide informed consent.
Inability to perform a post-surgical ultrasound, such as post-surgery hospitalization in the intensive care unit.
Women with preoperative coagulation disorders.
Women whose clinical condition requires a post-cesarean ultrasound examination.
Trial design
Treatments tested in this trial
- Ultrasound
- Standard care